Skip to main content

Peer Review reports

From: Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway

Original Submission
17 Jun 2022 Submitted Original manuscript
11 Sep 2022 Reviewed Reviewer Report - Ali Mansoor Alameri
19 Sep 2022 Reviewed Reviewer Report
9 Oct 2022 Author responded Author comments - Lin Lin
Resubmission - Version 2
9 Oct 2022 Submitted Manuscript version 2
31 Oct 2022 Author responded Author comments - Lin Lin
Resubmission - Version 3
31 Oct 2022 Submitted Manuscript version 3
10 Nov 2022 Author responded Author comments - Lin Lin
Resubmission - Version 4
10 Nov 2022 Submitted Manuscript version 4
14 Nov 2022 Reviewed Reviewer Report - Ali Mansoor Alameri
14 Nov 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
16 Nov 2022 Editorially accepted
24 Nov 2022 Article published 10.1186/s12905-022-02078-1

You can find further information about peer review here.

Back to article page